Skip to main content
Cureus logoLink to Cureus
. 2025 Nov 17;17(11):e97063. doi: 10.7759/cureus.97063

A Systematic Review of the Literature and Meta-Analysis of Autologous Fat Transfer: Fat Transfer Confers a 4.2% Incidence of Complications

Janak Bechar 1,✉, Thomas Kidd 1, Howard Chu 2, Joseph Hardwicke 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC12622863  PMID: 41255499

Abstract

Reporting of complications such as infection, necrosis, oil cysts and haematoma after fat transfer varies widely in the literature. Numerous variations in techniques (for example, cannula size, infiltration solution and fat-processing methods) have been described across a heterogeneous patient population for age, fat harvest location and recipient site. To date, no comprehensive review of the literature has been performed for all fat transfer procedures across the body. This study aims to provide novel information on the incidence of complications after fat transfer and is unique in its size and scope.

A systematic review of English literature was performed from 01/01/08 to 01/09/24 in MEDLINE, EMBASE, PUBMED and Cochrane Database of Systematic Reviews. Measured complication outcomes included necrosis, infection, induration, oil cysts, haematoma and pneumothorax. A random-effects model was employed to calculate the pooled complication incidence from selected articles.

After application of inclusion and exclusion criteria, 42 articles progressed to final analysis with a total of 6268 patients. Major complications investigated were fat necrosis (n=44, 0.7%), infection (n=66, 1%), induration and calcification (n=40, 0.6%), oil cysts (n=7, 0.1%) and haematoma (n=4, 0.06%). Pneumothorax post-procedure incidence was 0.1% (n=6). Overall complication incidence was 4.2%.

This study is unique in its scope and size and can be used for counselling patients in the pre-operative setting, providing a benchmark for surgeons to assess their practice with an overall complication incidence of 4.2%.

Keywords: autologous fat transfer, facial reconstruction, fat emulsion, fat graft survival, fat survival

Introduction and background

First described by Neuber G [1] in 1893, fat transfer, or autologous fat grafting, has been used in a variety of applications, including correcting breast contour defects after cancer surgery and lower limb defects after major trauma. Fat transfer is common, constituting 5.9% of all surgical aesthetic procedures, with more than 514,000 procedures performed globally in 2009 [2,3]. Over 70% of plastic surgeons use fat transfer to reconstruct breast defects [2,3]. Various techniques of fat harvest and transfer have been described, the most common of which is the Coleman fat grafting technique [3]. 

Ideal areas for fat harvest have yet to be defined [4]; a donor site is usually the anterior abdominal wall or thigh. Harvesting involves the aspiration of a fat solution from a given donor site through a metal cannula. The aspirate contains both adipocytes and adipocyte-derived stem cells, which increase regenerative potential and vascularisation of the graft [5-7].

Introduction of too much fat can lead to increased interstitial pressure and a collapse of capillaries, leading to hypoxia and graft loss [3,8,9]. However, the success of fat graft take is highly variable. A systematic review of 16 clinical studies revealed that fat survival can be as little as 15% from six months to 3.7 years of follow-up [10]. 

Factors affecting complications after fat transfer are poorly described in the literature. Early complications (<4 weeks from the time of procedure) may include local surgical site infection (0.7% donor or recipient site not requiring surgery [11]) and major complications such as pulmonary embolism. Major complications needing surgical intervention or hospitalisation have been described in a limited manner (incidence of ~6% in breast patients [11]), with the incidence of infections requiring surgery in breast patients being 2% [11]. Late complications (>4 weeks from procedure) may include graft necrosis, resorption and calcification [12]. Low-morbidity complications are the most numerous at 60% (such as swelling and induration) after breast fat transfer [12]. The incidence of fat necrosis ranges from 3% to 17% [13-16] and is hypothesised to be influenced by high fat-transfer volume [14] and operative technique. 

By pooling the complications of worldwide studies, the incidence of specific complications can be elucidated for a variety of techniques. To date, no comprehensive review of the literature has been performed for all fat transfer procedures across the body. This study aims to provide novel information on the incidence of complications after fat transfer and is unique in its size and scope, and will thus provide a benchmark for patient outcomes in surgical practice.

Review

Methods

Data Sources 

A systematic review of literature in English was performed using the following databases: MEDLINE, EMBASE, PUBMED, Cochrane Database of Systematic Reviews. The following keywords were used: [(Autologous fat grafting) OR (autologous fat transfer)] AND (complications). The publication date range was 01/01/2008-01/09/2024 to include more recent literature and practice. 

Study Selection

Each article was independently reviewed by two researchers (JAB and HC) for review. Eligibility criteria were defined using the population, intervention, comparator, outcome and study design approach (PICOS) [17]. Inclusion and exclusion criteria are summarised in Table 1. A subgroup of articles was included in a given paper if the data could be extracted and satisfied the inclusion and exclusion criteria.

Table 1. Inclusion and exclusion criteria applied to the literature search.

  Inclusion criteria Exclusion criteria Data extracted  
Population Human Non-human Age at operation  
Cosmetic, oncology and trauma patients Review articles; abstracts; conference proceedings; non-English language literature Country of origin  
Over 18 years  
Any country of origin  
Reported as a full article in an English-language journal  
Intervention Patients undergoing fat transfer Patients undergoing liposuction exclusively Surgical technique  
Single-stage grafting Multiple-stage grafting  
Study cohort ³10 patients Study cohort <10 patients  
Comparator Coleman vs. other techniques None Comparison group  
Donor/recipient sites  
Outcome Complications No complications recorded Acute and delayed complications  
Non-extractable data  
Study design Any clinical study design (randomised or non-randomised; comparative or non-comparative) Non-clinical study Study design; method of randomisation; years of study; length of follow-up  

Article selection was determined by a two-level screening process. The first level consisted of abstracts being reviewed for the inclusion and exclusion criteria. The second level consisted of the criteria being applied to the entirety of the article and data being extracted. Data were included from a given paper if both levels of inclusion and exclusion were passed. The final list of articles was reached via consensus of both researchers to ensure the inclusion and exclusion criteria were met. Article evaluation followed the guidance of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria [17-19]. 

The Methodological Index for Non-Randomized Studies (MINORS) instrument was used to assess the methodological quality of non-randomised studies [20]. Randomised control studies (RCTs) were evaluated for methodological quality using the Detsky score [21-23]. Appraisal for each non-randomised study yielded a score from a maximum of 16 for non-comparative studies and 24 for comparative studies, with a maximum score of 20 for randomised studies. MINORS or Detsky score of at least 75% of the maximum was deemed to be of high quality [21,22]. 

Data Extraction and Analysis 

Extracted data were recorded using Microsoft Excel (Microsoft Corp., Redmond, WA, USA). The agreement between researchers selecting papers was described using a kappa statistic. A proportion meta-analysis was used to describe complications after fat transfer. Primary data extraction included specific enumerated complications of fat necrosis, infection, induration/calcification, oil cysts and haematoma. Acute complications were classified as being less than four weeks from the time of surgery, whilst delayed complications were over four weeks after fat transfer. Secondary data outcomes extracted were geographic location of article, article type and duration of study, mean age of patient, follow-up time, operating time and fat processing method. Before analysis, the heterogeneity between studies was described using the Cochran's Q test [17]. Cochran's Q test indicated the presence of heterogeneity; hence, random-effects models were used throughout. Statistical analysis was performed using Stats Direct (StatsDirect Ltd, Cheshire, UK). Statistical significance threshold was determined as p <0.05. Data, where possible, will be described as mean or median with range values. 

Results 

On initial search, 413 articles were identified. After application of inclusion and exclusion criteria and removal of duplicates, 42 articles were included in the final analysis [14,24-65]. Of these articles, one was a randomised control trial (RCT) [39] and 41 were non-randomised. Of these 42 studies, two were comparative and 39 were non-comparative. The RCT Detsky score was 18 (considered high quality) with a non-randomised MINORS mean of 5.8. No non-randomised studies were considered to be of high quality. Figure 1 describes the selection algorithm. The agreement between researchers selecting papers revealed a kappa of 0.68.

Figure 1. Flow diagram showing the search algorithm on application of the inclusion and exclusion criteria.

Figure 1

A total of 6268 patients were included. Europe contributed 18 studies to this review (n=2524), with 14 from Asia (n=2372), eight from North America (n=962) and two from South America (n=410). The mean length of studies was 4.65 years (1-12 years). Article types were retrospective cohort (n=33), prospective cohort (n=8) and randomised control trial (n=1). The mean age of patients was 38.1 years (range 5.5-65 years). The mean follow-up after the first operation was 25.9 months (range 4-78 months). Mean operating time for fat transfer was 60.1 minutes (range 25-100 minutes). 

A wide range of surgical techniques and management protocols was described. Infiltration solution was used in 24 articles, with nine articles using Klein’s solution without specification of content (n=973). The median diameter of the harvest cannula was 3 mm (range 1.8-4 mm). The abdomen was the most common site for fat harvest (12 studies), followed by the thighs (11 studies), flanks (eight studies) and buttocks (four studies). 

Fat processing using centrifugation was used in 29 studies, whilst six studies used a gravity method using gauze. Of the 29 studies using centrifugation, the median parameters used were 3000 revolutions per minute (range 360-3000) for 3 minutes. Nineteen out of 26 articles used the Coleman centrifugation protocol of 3000 revolutions per minute for 3 minutes [2]. The mean total volume of fat transferred was 178.8 ml (range 2.1-1020 ml).

The crude incidence of complications was 4.2% (Figure 2). Specific enumerated complications (Figure 3) included fat necrosis (n=44, 0.7%), infection (n=66, 1%), induration and calcification (n=40, 0.6%), oil cysts (n=7, 0.1%) and haematoma (n=4, 0.06%). Post-procedure pneumothorax was demonstrated in six patients (0.1%). The remaining patients (n=65) had chronic oedema/bruising. By continent (Figure 4), Europe had a pooled proportion of complication incidence of 3.9% (95% CI: 3-5%), Asia 4.5% (95% CI: 4-5%), North America 5.3% (95% CI: 4-7%) and South America 3.9% (95% CI: 2-6%). 

Figure 2. Forest plot showing the proportion of reported complications after fat transfer (42 studies, 6268 patients).

Figure 2

Individual study results are given within the figure. A summary statistic of the random-effects model shows the total incidence of complications as 4.2% (95% CI=2.7-6.0). 

CI=confidence interval.

Source: [14,24-64].

Figure 3. Bar chart showing the number of patients for reported complications of fat transfer.

Figure 3

Specific enumerated complications included fat necrosis (n=44, 0.7%), infection (n=66, 1%), induration and calcification (n=40, 0.6%), oil cysts (n=7, 0.1%) and haematoma (n=4, 0.06%). Post-procedure pneumothorax was demonstrated in six patients (0.1%). The remaining patients (n=65) had chronic oedema/bruising.

Figure 4. Incidence of complications by continent.

Figure 4

n=total number of patients in a given geographical area and the incidence (percentage) of complications; CI=confidence interval.

Source: https://freesvg.org/map-of-the-world-outline.

Fat transfer to the breast had an overall complication rate of 7.5% (95% CI: 6-9, n=112/1487 patients), the face 4.0% (95% CI: 3-5, n=109/2691 patients), buttocks 4.8% (95% CI: 3-7, n=22/461 patients) and palate 3.1% (95% CI: 3-4, n=2/64 patients). Figure 5 illustrates the random-effects model for complications of each body site. Fat transfer to the face was a significant contributor to our study, with 2736 patients from 14 papers. The overall complication rate of autologous fat transfer to the face was 4.0% (109 out of 2736 patients). Fat transfer to the buttocks contributed to 461 patients from two papers, with a total complication rate of 4.7% (22 out of 461 patients). Fat transfer to the palate contributed to 64, respectively, from one paper, with a total complication rate of 3.1% (two out of 64 patients).

Figure 5. Forest plot showing the proportion of reported complications after fat transfer for each recipient body site.

Figure 5

Fat transfer to the breast had an overall complication rate of 7.5% (95% CI: 6-9, n=112/1487 patients), the face 4.0% (95% CI: 3-5, n=109/2691 patients), buttocks 4.8% (95% CI: 3-7, n=22/461 patients) and palate 3.1% (95% CI: 3-4, n=2/64 patients).

CI=confidence interval.

Discussion

Kim et al. [49] described the largest study in this literature review with n=1261 patients. The authors conducted a retrospective chart review of all patients in a four-year time period who underwent full-face fat injections for face augmentation using up to three injections. The first injection was using fresh fat, with the second and third using frozen fat [49]. The authors described complications in 62 patients, giving an overall complication rate of 4.9%. This was higher than the overall crude complication rate of 4.2% and also higher than the overall face fat transfer complication rate of 4.0% (95% CI: 3-5, n=109/2691 patients). Kim et al. [49] described acne as being the most common complication after the first face fat injection, calcification after the second fat injection, and calcification with fibrosis after the third fat injection. The authors also found that acne showed increased frequency following the use of fresh fat, whereas the use of frozen fat resulted in a higher frequency of calcification and fibrosis [49]. The authors also described a statistically higher complication rate for the second and third fat injections with frozen fat, after the first injection with fresh fat [49]. This may explain their higher complication rate compared to the average, though the mechanisms of this are not fully understood. The incidence of infection after fat transfer was a comparable 1.1% in their paper [49], with an overall infection incidence of 1% in all papers. Phulpin et al. [56] described the smallest article in this review by patient number. The authors described a retrospective case series of 11 radiotherapy patients who underwent head and neck fat grafting after abdominal fat harvest. The authors described no complications during their 39.9 (range 2-88)-month follow-up [56].

Spear et al. described an 8.5% incidence of infection and fat necrosis in 37 patients with reconstructed breasts [19]. The authors examined 68 reconstructed breasts with a total of 111 discrete fat injections. More than one fat injection was received by 71.4% of breasts [19]. This may account for the higher incidence of infection and fat necrosis compared to our study (4.2%). In addition, Spear et al. [19] observed that patients had greater complications with increased volumes of fat grafting (184 ml versus 99 ml, p=0.0115). Our study had a mean breast transferred volume of 263.1 ml, considerably higher than the 184 ml of the Spear et al. cohort, and with a lower complication incidence. The higher rate of infection and fat necrosis observed in the Spear et al. [19] study may be due to the study’s small cohort of 37 breast patients, compared to our study of 2894 breast patients. 

Largo et al. [11] performed a literature review of autologous fat grafting to healthy breast tissue, including 36 articles and 1453 patients after application of their inclusion and exclusion criteria. Their study states an overall complication rate of 15.6% with a mean follow-up of 16.3 months [11] compared with 8.0% in our study. Largo et al. had a higher complication rate that can be explained by the authors including dysaesthesia, lymphadenopathy and unsatisfactory cosmesis into their cohort as complications. Their overall rate of infection was low at 0.7% (10 out of 1453 patients) [11] compared to our study of 2.2% (32 out of 1487 patients). 

Uda et al. [59] demonstrated the highest complication rate in our study, with 13 out of 14 patients suffering complications (11 patients with dermatitis and two patients with fat necrosis). Fat transfer was performed in conjunction with the Brava device (a vacuum-assisted method of breast augmentation) [59]. This high incidence of complications may be explained by all patients in this study undergoing radiotherapy, impairing the quality of the skin [59]. Additionally, the Brava device may introduce a bias into this study, as complications may be attributed to the device, rather than fat transfer. 

This study was limited by a data set that was heterogeneous, and this is a limitation of this review. A paucity of homogeneous patient comorbidity data made it challenging to draw adequate conclusions about complications linked to patient health. A large variety of harvest and fat-processing techniques were used from a wide range of donor sites (e.g., lateral thigh, abdomen, flank and gluteal). Infiltration solution used before fat harvest was also varied in terms of the volume used and constituents (saline 0.9% vs Ringer’s lactate, concentration of adrenaline and choice of local anaesthetic). Fat processing was also not uniform, ranging from using a centrifuge to purified fat, mesh strainers and other filters. As such, sub-group analysis was challenging to compare ‘like with like’ datasets. 

Conclusions

We would recommend standardisation in complication recording and classification. Given the variation in harvest, processing and grafting methodology, we would also recommend multi-centre randomised control trials of surgical procedure to optimise fat grafting and limit complications in the future.

To our knowledge, we present the largest literature review of autologous fat transfer in the literature. This study is unique in its scope and size and can be used for counselling patients in the pre-operative setting and providing a benchmark for surgeons to assess their practice.

Disclosures

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Author Contributions

Concept and design:  Janak Bechar, Thomas Kidd, Howard Chu, Joseph Hardwicke

Acquisition, analysis, or interpretation of data:  Janak Bechar, Thomas Kidd

Drafting of the manuscript:  Janak Bechar, Thomas Kidd, Howard Chu, Joseph Hardwicke

Critical review of the manuscript for important intellectual content:  Janak Bechar, Thomas Kidd

Supervision:  Joseph Hardwicke

References

  • 1.Asepsis und kunstliche Blutleere. Neuber G. Verhandl d deutsh Gesellsch F Chir (Berl) 1910;22:159. [Google Scholar]
  • 2.Current trends in breast reconstruction: Survey of American Society of Plastic Surgeons 2010. Gurunluoglu R, Gurunluoglu A, Williams SA, Tebockhorst S. Ann Plast Surg. 2013;70:103–110. doi: 10.1097/SAP.0b013e31822ed5ce. [DOI] [PubMed] [Google Scholar]
  • 3.Autologous fat transfer to the subcutaneous tissue in the context of breast reconstructive procedures. Szychta P, Zadrozny M, Rykala J, Banasiak L, Witmanowski H. Postepy Dermatol Alergol. 2016;33:323–328. doi: 10.5114/ada.2016.62835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Ferlay J, Soerjomataram I, Dikshit R, et al. Int J Cancer. 2015;136:0–86. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
  • 5.Towards more rationalized approach to autologous fat grafting. Pu LL. J Plast Reconstr Aesthet Surg. 2012;65:413–419. doi: 10.1016/j.bjps.2011.09.033. [DOI] [PubMed] [Google Scholar]
  • 6.Content of the growth factors bFGF, IGF-1, VEGF, and PDGF-BB in freshly harvested lipoaspirate after centrifugation and incubation. Pallua N, Pulsfort AK, Suschek C, Wolter TP. Plast Reconstr Surg. 2009;123:826–833. doi: 10.1097/PRS.0b013e318199ef31. [DOI] [PubMed] [Google Scholar]
  • 7.The effect of processing technique on fat graft survival. Canizares O, Thomson JE, Allen RJ, et al. Plast Reconstr Surg. 2017;140:933–943. doi: 10.1097/PRS.0000000000003812. [DOI] [PubMed] [Google Scholar]
  • 8.Megavolume autologous fat transfer: part II. Practice and techniques. Khouri RK, Rigotti G, Cardoso E, Khouri RK Jr, Biggs TM. Plast Reconstr Surg. 2014;133:1369–1377. doi: 10.1097/PRS.0000000000000179. [DOI] [PubMed] [Google Scholar]
  • 9.Blindness and necrotizing fasciitis after liposuction and fat transfer. Sherman JE, Fanzio PM, White H, Leifer D. Plast Reconstr Surg. 2010;126:1358–1363. doi: 10.1097/PRS.0b013e3181ea4576. [DOI] [PubMed] [Google Scholar]
  • 10.A systemic review of autologous fat grafting survival rate and related severe complications. Yu NZ, Huang JZ, Zhang H, et al. Chin Med J (Engl) 2015;128:1245–1251. doi: 10.4103/0366-6999.156142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Efficacy, safety and complications of autologous fat grafting to healthy breast tissue: A systematic review. Largo RD, Tchang LA, Mele V, Scherberich A, Harder Y, Wettstein R, Schaefer DJ. J Plast Reconstr Aesthet Surg. 2014;67:437–448. doi: 10.1016/j.bjps.2013.11.011. [DOI] [PubMed] [Google Scholar]
  • 12.Autologous fat transfer for breast augmentation: A review. Al Sufyani MA, Al Hargan AH, Al Shammari NA, Al Sufyani MA. Dermatol Surg. 2016;42:1235–1242. doi: 10.1097/DSS.0000000000000791. [DOI] [PubMed] [Google Scholar]
  • 13.Autologous cell-enriched fat grafting for breast augmentation. Kamakura T, Ito K. Aesthetic Plast Surg. 2011;35:1022–1030. doi: 10.1007/s00266-011-9727-7. [DOI] [PubMed] [Google Scholar]
  • 14.Autologous fat grafting to the breast for cosmetic enhancement: Experience in 66 patients with long-term follow up. Zheng DN, Li QF, Lei H, et al. J Plast Reconstr Aesthet Surg. 2008;61:792–798. doi: 10.1016/j.bjps.2007.08.036. [DOI] [PubMed] [Google Scholar]
  • 15.Fistula incidence after primary cleft palate repair: A systematic review of the literature. Hardwicke JT, Landini G, Richard BM. Plast Reconstr Surg. 2014;134:618–627. doi: 10.1097/PRS.0000000000000548. [DOI] [PubMed] [Google Scholar]
  • 16.Fistula after single-stage primary hypospadias repair - A systematic review of the literature. Hardwicke JT, Bechar JA, Hodson J, Osmani O, Park AJ. J Plast Reconstr Aesthet Surg. 2015;68:1647–1655. doi: 10.1016/j.bjps.2015.07.024. [DOI] [PubMed] [Google Scholar]
  • 17.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG. Int J Surg. 2010;8:336–341. [PMC free article] [PubMed] [Google Scholar]
  • 18.The combination of estimates from different experiments. Cochran WG. https://www.scirp.org/reference/referencespapers?referenceid=2018487 Biometrics. 1954;10:101–129. [Google Scholar]
  • 19.Fat injection to correct contour deformities in the reconstructed breast. Spear SL, Wilson HB, Lockwood MD. Plast Reconstr Surg. 2005;116:1300–1305. doi: 10.1097/01.prs.0000181509.67319.cf. [DOI] [PubMed] [Google Scholar]
  • 20.Methodological index for non-randomized studies (MINORS): Development and validation of a new instrument. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. ANZ J Surg. 2003;73:712–716. doi: 10.1046/j.1445-2197.2003.02748.x. [DOI] [PubMed] [Google Scholar]
  • 21.The quality of reporting of randomized trials in the Journal of Bone and Joint Surgery from 1988 through 2000. Bhandari M, Richards RR, Sprague S, Schemitsch EH. J Bone Joint Surg Am. 2002;84:388–396. doi: 10.2106/00004623-200203000-00009. [DOI] [PubMed] [Google Scholar]
  • 22.Graft tensioning in anterior cruciate ligament reconstruction: A systematic review of randomized controlled trials. Arneja S, McConkey MO, Mulpuri K, Chin P, Gilbart MK, Regan WD, Leith JM. Arthroscopy. 2009;25:200–207. doi: 10.1016/j.arthro.2008.07.010. [DOI] [PubMed] [Google Scholar]
  • 23.Incorporating variations in the quality of individual randomized trials into meta-analysis. Detsky AS, Naylor CD, O’Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255–265. doi: 10.1016/0895-4356(92)90085-2. [DOI] [PubMed] [Google Scholar]
  • 24.Immediate large-volume grafting of autologous fat to the breast following implant removal. Abboud MH, Dibo SA. Aesthet Surg J. 2015;35:819–829. doi: 10.1093/asj/sjv073. [DOI] [PubMed] [Google Scholar]
  • 25.Power-assisted gluteal augmentation: A new technique for sculpting, harvesting, and transferring fat. Abboud MH, Dibo SA, Abboud NM. Aesthet Surg J. 2015;35:987–994. doi: 10.1093/asj/sjv161. [DOI] [PubMed] [Google Scholar]
  • 26.Correction of sequelae of rhinoplasty by lipofilling. Baptista C, Nguyen PS, Desouches C, Magalon G, Bardot J, Casanova D. J Plast Reconstr Aesthet Surg. 2013;66:805–811. doi: 10.1016/j.bjps.2013.02.020. [DOI] [PubMed] [Google Scholar]
  • 27.Effectiveness and safety of autologous fat grafting to the soft palate alone. Boneti C, Ray PD, Macklem EB, Kohanzadeh S, de la Torre J, Grant JH. Ann Plast Surg. 2015;74 Suppl 4:0–2. doi: 10.1097/SAP.0000000000000442. [DOI] [PubMed] [Google Scholar]
  • 28.Role of lipomodelling in improving aesthetic outcomes in patients undergoing immediate and delayed reconstructive breast surgery. Bonomi R, Betal D, Rapisarda IF, Kalra L, Sajid MS, Johri A. Eur J Surg Oncol. 2013;39:1039–1045. doi: 10.1016/j.ejso.2013.07.001. [DOI] [PubMed] [Google Scholar]
  • 29.Oncological safety of autologous fat grafting after breast conservative treatment: a prospective evaluation. Brenelli F, Rietjens M, De Lorenzi F, et al. Breast J. 2014;20:159–165. doi: 10.1111/tbj.12225. [DOI] [PubMed] [Google Scholar]
  • 30.Achieving ideal lower face aesthetic contours: Combination of tridimensional fat grafting to the chin with masseter botulinum toxin injection. Chang CS, Kang GC. Aesthet Surg J. 2016;36:1093–1100. doi: 10.1093/asj/sjw082. [DOI] [PubMed] [Google Scholar]
  • 31.Autologous fat grafting for breast augmentation in underweight women. Chiu CH. Aesthet Surg J. 2014;34:1066–1082. doi: 10.1177/1090820X14540679. [DOI] [PubMed] [Google Scholar]
  • 32.Secondary lipofilling after breast reconstruction with implants. Cigna E, Ribuffo D, Sorvillo V, Atzeni M, Piperno A, Calò PG, Scuderi N. https://pubmed.ncbi.nlm.nih.gov/23161048/ Eur Rev Med Pharmacol Sci. 2012;16:1729–1734. [PubMed] [Google Scholar]
  • 33.Evaluation of clinical outcomes and aesthetic results after autologous fat grafting for contour deformities of the reconstructed breast. de Blacam C, Momoh AO, Colakoglu S, Tobias AM, Lee BT. Plast Reconstr Surg. 2011;128:411–418. doi: 10.1097/PRS.0b013e31822b669f. [DOI] [PubMed] [Google Scholar]
  • 34.Tuberous breast correction by fat grafting. Delay E, Sinna R, Ho Quoc C. Aesthet Surg J. 2013;33:522–528. doi: 10.1177/1090820X13480641. [DOI] [PubMed] [Google Scholar]
  • 35.Fat grafting with tissue liquefaction technology as an adjunct to breast reconstruction. Dolen U, Cohen JB, Overschmidt B, Tenenbaum MM, Myckatyn TM. Aesthetic Plast Surg. 2016;40:854–862. doi: 10.1007/s00266-016-0690-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Calf augmentation with autologous tissue injection. Erol OO, Gürlek A, Agaoglu G. Plast Reconstr Surg. 2008;121:2127–2133. doi: 10.1097/PRS.0b013e3181708152. [DOI] [PubMed] [Google Scholar]
  • 37.Microfat grafting in nasal surgery. Erol OO. Aesthet Surg J. 2014;34:671–686. doi: 10.1177/1090820X14529444. [DOI] [PubMed] [Google Scholar]
  • 38.Regenerative surgery in the treatment of cosmetic defect following Nuss procedure. Facchini F, Ghionzoli M, Martin A, Tanini S, Ugolini S, Lo Piccolo R, Messineo A. J Laparoendosc Adv Surg Tech A. 2017;27:748–753. doi: 10.1089/lap.2016.0217. [DOI] [PubMed] [Google Scholar]
  • 39.Double-blind clinical trial to compare autologous fat grafts versus autologous fat grafts with PDGF: No effect of PDGF. Fontdevila J, Guisantes E, Martínez E, Prades E, Berenguer J. Plast Reconstr Surg. 2014;134:219–230. doi: 10.1097/PRS.0000000000000409. [DOI] [PubMed] [Google Scholar]
  • 40.Fat grafting in immediate breast reconstruction. Avoiding breast sequelae. Moltó García R, González Alonso V, Villaverde Doménech ME. Breast Cancer. 2016;23:134–140. doi: 10.1007/s12282-014-0541-3. [DOI] [PubMed] [Google Scholar]
  • 41.Breast reconstruction de novo by water-jet assisted autologous fat grafting--A retrospective study. Hoppe DL, Ueberreiter K, Surlemont Y, Peltoniemi H, Stabile M, Kauhanen S. Ger Med Sci. 2013;11:0. doi: 10.3205/000185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Alleviation of neuropathic scar pain using autologous fat grafting. Huang SH, Wu SH, Chang KP, et al. Ann Plast Surg. 2015;74 Suppl 2:0–104. doi: 10.1097/SAP.0000000000000462. [DOI] [PubMed] [Google Scholar]
  • 43.Autologous fat grafting and breast cancer recurrences: Retrospective analysis of a series of 100 procedures in 64 patients. Ihrai T, Georgiou C, Machiavello JC, et al. J Plast Surg Hand Surg. 2013;47:273–275. doi: 10.3109/2000656X.2012.759583. [DOI] [PubMed] [Google Scholar]
  • 44.Efficacy and safety of penile girth enhancement by autologous fat injection for patients with thin penises. Kang DH, Chung JH, Kim YJ, Lee HN, Cho SH, Chang TH, Lee SW. Aesthetic Plast Surg. 2012;36:813–818. doi: 10.1007/s00266-012-9891-4. [DOI] [PubMed] [Google Scholar]
  • 45.Microautologous fat transplantation for primary augmentation rhinoplasty: Long-term monitoring of 198 Asian patients. Kao WP, Lin YN, Lin TY, et al. Aesthet Surg J. 2016;36:648–656. doi: 10.1093/asj/sjv253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Autologous fat grafting after breast reconstruction in postmastectomy patients: Complications, biopsy rates, and locoregional cancer recurrence rates. Kaoutzanis C, Xin M, Ballard TN, et al. Ann Plast Surg. 2016;76:270–275. doi: 10.1097/SAP.0000000000000561. [DOI] [PubMed] [Google Scholar]
  • 47.Brava and autologous fat transfer is a safe and effective breast augmentation alternative: Results of a 6-year, 81-patient, prospective multicenter study. Khouri RK, Eisenmann-Klein M, Cardoso E, Cooley BC, Kacher D, Gombos E, Baker TJ. Plast Reconstr Surg. 2012;129:1173–1187. doi: 10.1097/PRS.0b013e31824a2db6. [DOI] [PubMed] [Google Scholar]
  • 48.Tissue-engineered breast reconstruction with Brava-assisted fat grafting: A 7-year, 488-patient, multicenter experience. Khouri RK, Rigotti G, Khouri RK Jr, et al. Plast Reconstr Surg. 2015;135:643–658. doi: 10.1097/PRS.0000000000001039. [DOI] [PubMed] [Google Scholar]
  • 49.An analysis of the experiences of 62 patients with moderate complications after full-face fat injection for augmentation. Kim SM, Kim YS, Hong JW, Roh TS, Rah DK. Plast Reconstr Surg. 2012;129:1359–1368. doi: 10.1097/PRS.0b013e31824ecbb0. [DOI] [PubMed] [Google Scholar]
  • 50.Effect of autologous fat injection on lower eyelid position. Le TP, Peckinpaugh J, Naficy S, Amadi AJ. Ophthalmic Plast Reconstr Surg. 2014;30:504–507. doi: 10.1097/IOP.0000000000000160. [DOI] [PubMed] [Google Scholar]
  • 51.Treatment of velopharyngeal insufficiency by autologous fat injection. Leuchter I, Schweizer V, Hohlfeld J, Pasche P. Eur Arch Otorhinolaryngol. 2010;267:977–983. doi: 10.1007/s00405-009-1157-7. [DOI] [PubMed] [Google Scholar]
  • 52.Autologous fat graft by needle: Analysis of complications after 1000 patients. Maione L, Vinci V, Klinger M, Klinger FM, Caviggioli F. Ann Plast Surg. 2015;74:277–280. doi: 10.1097/SAP.0000000000000050. [DOI] [PubMed] [Google Scholar]
  • 53.Autologous gluteal lipograft. Nicareta B, Pereira LH, Sterodimas A, Illouz YG. Aesthetic Plast Surg. 2011;35:216–224. doi: 10.1007/s00266-010-9590-y. [DOI] [PubMed] [Google Scholar]
  • 54.Long-term clinical outcomes of fat grafting by low-pressure aspiration and slow centrifugation (Lopasce technique) for different indications. Ozkaya O, Egemen O, Barutça SA, Akan M. J Plast Surg Hand Surg. 2013;47:394–398. doi: 10.3109/2000656X.2013.771585. [DOI] [PubMed] [Google Scholar]
  • 55.Autologous fat grafting in facial volumetric restoration. Piombino P, Marenzi G, Dell'Aversana Orabona G, Califano L, Sammartino G. J Craniofac Surg. 2015;26:756–759. doi: 10.1097/SCS.0000000000001663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Rehabilitation of irradiated head and neck tissues by autologous fat transplantation. Phulpin B, Gangloff P, Tran N, Bravetti P, Merlin JL, Dolivet G. Plast Reconstr Surg. 2009;123:1187–1197. doi: 10.1097/PRS.0b013e31819f2928. [DOI] [PubMed] [Google Scholar]
  • 57.Long-term outcomes following fat grafting in prosthetic breast reconstruction: A comparative analysis. Seth AK, Hirsch EM, Kim JY, Fine NA. Plast Reconstr Surg. 2012;130:984–990. doi: 10.1097/PRS.0b013e318267d34d. [DOI] [PubMed] [Google Scholar]
  • 58.Augmentation blepharoplasty: A review of 500 consecutive patients. Tonnard PL, Verpaele AM, Zeltzer AA. Aesthet Surg J. 2013;33:341–352. doi: 10.1177/1090820X13478966. [DOI] [PubMed] [Google Scholar]
  • 59.Brava and autologous fat grafting for breast reconstruction after cancer surgery. Uda H, Sugawara Y, Sarukawa S, Sunaga A. Plast Reconstr Surg. 2014;133:203–213. doi: 10.1097/01.prs.0000437256.78327.12. [DOI] [PubMed] [Google Scholar]
  • 60.Augmentation phalloplasty with autologous dermal fat graft in the treatment of "small penis". Xu L, Zhao M, Chen W, et al. Ann Plast Surg. 2016;77 Suppl 1:0–5. doi: 10.1097/SAP.0000000000000782. [DOI] [PubMed] [Google Scholar]
  • 61.Autologous fat grafting with combined three-dimensional and mirror-image analyses for progressive hemifacial atrophy. Yang X, Wu R, Bi H, Lu H, Jia Z, Jin X, Qi Z. Ann Plast Surg. 2016;77:308–313. doi: 10.1097/SAP.0000000000000641. [DOI] [PubMed] [Google Scholar]
  • 62.Autologous fat grafting in lip reconstruction following hemangioma treatment. Yin J, Li H, Yin N, et al. J Craniofac Surg. 2013;24:346–349. doi: 10.1097/SCS.0b013e318288b917. [DOI] [PubMed] [Google Scholar]
  • 63.Sharp-needle intradermal fat grafting (SNIF) Zeltzer AA, Tonnard PL, Verpaele AM. Aesthet Surg J. 2012;32:554–561. doi: 10.1177/1090820X12445082. [DOI] [PubMed] [Google Scholar]
  • 64.Bicompartmental breast lipostructuring. Zocchi ML, Zuliani F. Aesthetic Plast Surg. 2008;32:313–328. doi: 10.1007/s00266-007-9089-3. [DOI] [PubMed] [Google Scholar]
  • 65.The tumescent technique for liposuction surgery. Klein JA. https://www.liposuction101.com/wp-content/uploads/2011/07/The_Tumescent_Technique_for_Liposuction_Surgery.pdf AM J Cosmet Surg. 1987;4:263–267. [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES